Prof Dr Susan O'Brien - Lessons Learned From the CAPTIVATE Trial of Ibrutinib Plus Venetoclax in CLL

[Jm954]

From CLL In Focus October 2021

Excellent interview with Prof Dr Susan Obrien on the results and information from the CAPTIVATE Study

hematologyandoncology.net/f...

Jackie

[Mystic75]

Thanks, Jackie!

[bennevisplace]

Thanks!

I have to admit, I was irritated by Dr O'Brien's habit of starting every answer with "So... (a Zuckerbergian affectation copied by millions).

Then it dawned. Her initials are SO.

[Jm954 Administrator in reply to bennevisplace]

I was the same! 😜

[bennevisplace]

It's a useful summary.

Why are there so many candidate inhibitors of BTK and so few of BCL2?

[Peggy4]

So…….that was interesting 🤣Thank you Jackie.

Peggy

[Jm954 Administrator in reply to Peggy4]

😂😂

[Peggy4 in reply to Jm954]

Clever lady though. I enjoy listening to her.